Evidence map›Paper›PMID 36558542›Full record

ArticleNutrients2022

Xue Han, Miaomiao Li, Lijun Sun, Xinjuan Liu, Yue Yin, Jianyu Hao, Weizhen Zhang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Therapeutic Potential of Kinkeliba (Molecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Bioactive Potential of Elderberry (Molecules (Basel, Switzerland) · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xue HanDepartment of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100191, China.
Miaomiao LiDepartment of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Lijun SunDepartment of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100191, China.
Xinjuan LiuDepartment of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Yue YinDepartment of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100191, China.
Jianyu HaoDepartment of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Weizhen ZhangDepartment of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100191, China.ORCID 0000-0001-8791-2798
Peking University · CNCapital Medical University · CN

Funding

National Natural Science Foundation of China 81730020, 81930015, 82100912, and 82100923
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease characterized by intestinal inflammatory cell infiltration and intestinal mucosal damage. The mechanism by which diet contributes to the pathogenesis of IBD remains largely unknown. In this study, we explored the therapeutic effect of

Indexed as

ColitisGastrointestinal MicrobiomeInflammatory Bowel DiseasesAnimalsChronic DiseaseColonDextran SulfateDisease Models, AnimalHydroxybenzoatesIntestinal MucosaMiceMice, Inbred C57BLDextran SulfateHydroxybenzoatesphenolic acidcolitisgoblet cellsgut microbiotamucosal barrierp-hydroxybenzoic acid

Identifiers

PMID36558542
PMCPMC9784546
OpenAlexW4312210868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.